Cellectar Biosciences Inc (CLRB)

[Cshom67]

Here's some news for you Sunofwolf: CLASS ACTION LAWSUIT coming up!

It's obvious to me that this co has PCG churn their stock. Just look at the volume spikes on e.g. 5/20/16, 5/23/16, 1/24/17, the days on which 4-10x of CLRB's float (4.26M) were traded.

If you have ever heard /read about choleric lil' Jimmy and Jeff Ramson, you know what is going on here...

I am still waiting for the scientific evidence showing that their fatty acid vehicle can deliver "more than 30-fold" (as stated in their 6/15/16 PR) Taxol to tumors than the drug in its free form. The announced comparison against Abraxane was never shown, so draw your own conclusions from that.

As for their CLR131 asset: The 12/1/16 PR was missing an ORR statement, which tells me that their ORR up until then was 0%. That's pretty bad.
Same in the 12/6/16 PR for the ASH conference... Only one patient with PFS, 0% ORR in total. If the ORR were >0%, this company would have released 5 PRs about it.

According to LinkedIn, all PhDs and key employees jumped ship last year. Mgmt team is uneducated and pathetic for a biotech.

So yeah. Do your own DD before posting here. If you want to make any money with CLRB, you will a) have to join the class action law suit or b) short the crap out of this pos. It ain't going anywhere...